Combining chemotherapy and hormone therapy for the treatment of luminal metastat...
Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Combining chemotherapy and hormone therapy for the treatment of luminal metastatic breast cancer ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
27 Jan 2020
Ductal carcinoma in situ, are we over-treating it?
Prof Cheng-Har Yip - Subang Jaya Medical Centre, Kuala Lumpur, Malaysia
Ductal carcinoma in situ, are we over-treating it? ( Prof Cheng-Har Yip - Subang Jaya Medical Centre, Kuala Lumpur, Malaysia )
27 Jan 2020
An overview of breast cancer in Malaysia
Prof Cheng-Har Yip - Subang Jaya Medical Centre, Kuala Lumpur, Malaysia
An overview of breast cancer in Malaysia ( Prof Cheng-Har Yip - Subang Jaya Medical Centre, Kuala Lumpur, Malaysia )
27 Jan 2020
Intraoperative radiotherapy for breast cancer
Prof Cheng-Har Yip - Subang Jaya Medical Centre, Kuala Lumpur, Malaysia
Intraoperative radiotherapy for breast cancer ( Prof Cheng-Har Yip - Subang Jaya Medical Centre, Kuala Lumpur, Malaysia )
27 Jan 2020
MRI morphology of malignant breast cancer lesions
Dr Hannah Chung - University of Texas, Houston, USA
MRI morphology of malignant breast cancer lesions ( Dr Hannah Chung - University of Texas, Houston, USA )
27 Jan 2020
Benign lesions that mimic breast cancer
Dr Hannah Chung - University of Texas, Houston, USA
Benign lesions that mimic breast cancer ( Dr Hannah Chung - University of Texas, Houston, USA )
27 Jan 2020
Breast cancer in the young
Dr Hannah Chung - University of Texas, Houston, USA
Breast cancer in the young ( Dr Hannah Chung - University of Texas, Houston, USA )
27 Jan 2020
The age of genomic profiling
Prof Cengiz Yakicier - Acıbadem University, Istanbul, Turkey
The age of genomic profiling ( Prof Cengiz Yakicier - Acıbadem University, Istanbul, Turkey )
27 Jan 2020
Identifying BRCA mutations for breast and ovarian cancer
Prof Alena Savanevich - Grodno State Medical University, Grodno, Belarus
Identifying BRCA mutations for breast and ovarian cancer ( Prof Alena Savanevich - Grodno State Medical University, Grodno, Belarus )
27 Jan 2020
HER2CLIMB: Investigating tucatinib with capecitabine and trastuzumab in HER2-pos...
Dr Rashmi Murthy - MD Anderson Cancer Center, Houston, USA
HER2CLIMB: Investigating tucatinib with capecitabine and trastuzumab in HER2-positive metastatic breast cancer ( Dr Rashmi Murthy - MD Anderson Cancer Center, Houston, USA )
23 Jan 2020
Oral paclitaxel yields better outcomes than IV paclitaxel in metastatic breast c...
Dr Gerardo Umanzor - Hospital del Valle, San Pedro Sula, Honduras
Oral paclitaxel yields better outcomes than IV paclitaxel in metastatic breast cancer ( Dr Gerardo Umanzor - Hospital del Valle, San Pedro Sula, Honduras )
23 Jan 2020
Selective oestrogen receptor degraders as treatment for ER positive/HER2 negativ...
Dr Philippe Aftimos - Institut Jules Bordet, Brussels, Belgium
Selective oestrogen receptor degraders as treatment for ER positive/HER2 negative advanced/metastatic breast cancer ( Dr Philippe Aftimos - Institut Jules Bordet, Brussels, Belgium )
19 Dec 2019